Ethics approval
An independent ethics committee/institutional review board approved the final clinical study protocol, including the final version of the informed consent form and any other written information provided to the patients. This included approval of the exploratory biomarker and pharmacogenetic research and associated consent forms. This study was conducted in accordance with the Declaration of Helsinki and the International Council for Harmonisation, good clinical practice, applicable regulatory requirements, and the AstraZeneca policy on bioethics.